NATIVE GENE THERAPY
associated with 20 other trademarks
Pharmaceutical agents that target DNA structure to treat various diseases, namely, monogenic diseases, cancer, infectious disease, immune disease, hem...

Words that describe this trademark:

target dna  monogenic diseases  dna structure  diseases cancer  various diseases  agents target  pharmaceutical  diseases  structure  treat 

Serial Number:

97079718

Mark:

NATIVE GENE THERAPY

Status:

Abandoned-Failure to Respond

Status Date:

06-15-2023

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceutical agents that target DNA structure to treat various diseases, namely, monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

N/A

Mark Drawing Status:

4

Abandon Date:

06-02-2023

Business Name:

600 ATLANTIC AVENUE

Recent Trademark filings by this company